Developing advanced tools to enhance immune responses for treating diseases
The Johns Hopkins Translational ImmunoEngineering (JH-TIE)
This study is all about finding new ways to boost your immune system to better fight diseases like cancer and autoimmune disorders, and it's designed for anyone interested in improving treatments for these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11134598 on NIH RePORTER |
What this research studies
The Johns Hopkins Translational ImmunoEngineering program focuses on creating innovative tools and methods to improve immune responses against various diseases, including cancer and autoimmune disorders. This multidisciplinary approach involves collaboration with both scientific and clinical communities to ensure that the developed technologies are effective and applicable in real-world settings. The program aims to activate T cells and deliver immunological agents precisely to target cells, enhancing the effectiveness of immunotherapy. Over the next five years, the research will also address immune and inflammatory diseases through the development of new techniques and protocols.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with cancer or autoimmune conditions who may benefit from enhanced immunotherapy treatments.
Not a fit: Patients with conditions unrelated to immune responses or those who do not qualify for immunotherapy may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective immunotherapies for patients suffering from cancer and autoimmune diseases.
How similar studies have performed: Previous research in immunoengineering has shown promising results, indicating that this approach has the potential for significant advancements in treatment.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Schneck, Jonathan P — Johns Hopkins University
- Study coordinator: Schneck, Jonathan P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.